Principal Financial Group Inc. trimmed its holdings in National Health Investors, Inc. (NYSE:NHI - Free Report) by 11.4% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,565,674 shares of the real estate investment trust's stock after selling 201,140 shares during the quarter. Principal Financial Group Inc. owned approximately 3.45% of National Health Investors worth $131,609,000 at the end of the most recent quarter.
Other institutional investors and hedge funds have also recently bought and sold shares of the company. Zimmer Partners LP acquired a new position in National Health Investors in the third quarter valued at $25,218,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its holdings in shares of National Health Investors by 332.0% during the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 242,326 shares of the real estate investment trust's stock worth $20,370,000 after buying an additional 186,238 shares during the last quarter. Charles Schwab Investment Management Inc. increased its position in National Health Investors by 17.0% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 852,377 shares of the real estate investment trust's stock valued at $71,651,000 after acquiring an additional 123,596 shares during the period. Waterfront Capital Partners LLC purchased a new stake in National Health Investors during the 3rd quarter valued at approximately $10,097,000. Finally, Lee Danner & Bass Inc. acquired a new stake in National Health Investors during the 2nd quarter worth approximately $5,089,000. Hedge funds and other institutional investors own 62.51% of the company's stock.
Wall Street Analysts Forecast Growth
A number of research analysts have recently issued reports on the company. Bank of America initiated coverage on National Health Investors in a report on Tuesday, September 24th. They issued a "buy" rating and a $92.00 target price on the stock. Wells Fargo & Company cut shares of National Health Investors from an "overweight" rating to an "equal weight" rating and raised their target price for the stock from $81.00 to $86.00 in a research note on Tuesday, October 1st. StockNews.com lowered shares of National Health Investors from a "buy" rating to a "hold" rating in a research note on Tuesday, October 15th. Finally, Truist Financial increased their price target on shares of National Health Investors from $65.00 to $78.00 and gave the stock a "hold" rating in a report on Friday, August 30th. Three research analysts have rated the stock with a hold rating and four have given a buy rating to the company. According to data from MarketBeat.com, National Health Investors has a consensus rating of "Moderate Buy" and a consensus price target of $76.33.
Check Out Our Latest Report on NHI
National Health Investors Price Performance
Shares of NYSE:NHI traded up $1.01 on Friday, reaching $69.85. 750,877 shares of the company were exchanged, compared to its average volume of 204,402. The company has a current ratio of 10.29, a quick ratio of 10.29 and a debt-to-equity ratio of 0.92. National Health Investors, Inc. has a 1-year low of $51.59 and a 1-year high of $86.13. The company has a 50-day moving average of $76.02 and a 200-day moving average of $75.54. The firm has a market cap of $3.17 billion, a price-to-earnings ratio of 24.00, a price-to-earnings-growth ratio of 4.86 and a beta of 1.04.
National Health Investors (NYSE:NHI - Get Free Report) last issued its earnings results on Tuesday, November 5th. The real estate investment trust reported $0.65 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.07 by ($0.42). The company had revenue of $63.32 million during the quarter, compared to analysts' expectations of $67.93 million. National Health Investors had a net margin of 38.53% and a return on equity of 10.11%. The company's quarterly revenue was up 1.7% on a year-over-year basis. During the same period last year, the business posted $1.08 earnings per share. Equities analysts forecast that National Health Investors, Inc. will post 4.42 earnings per share for the current fiscal year.
National Health Investors Announces Dividend
The company also recently declared a quarterly dividend, which will be paid on Wednesday, January 29th. Stockholders of record on Tuesday, December 31st will be given a $0.90 dividend. This represents a $3.60 dividend on an annualized basis and a dividend yield of 5.15%. The ex-dividend date is Tuesday, December 31st. National Health Investors's dividend payout ratio is currently 123.71%.
About National Health Investors
(
Free Report)
Incorporated in 1991, National Health Investors, Inc NYSE: NHI is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.
See Also
Before you consider National Health Investors, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and National Health Investors wasn't on the list.
While National Health Investors currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.